Rasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature B-NHL: a Children's Oncology Group Report
Author:
Affiliation:
1. Mayo Clinic; Rochester; MN; USA
2. New York Medical College; Valhalla; NY; USA
3. University of Utah; Salt Lake City; UT; USA
4. Medical City Children's Hospital; Dallas; TX; USA
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12542/fullpdf
Reference20 articles.
1. Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study;Bowman;Journal of Clinical Oncology,1996
2. Tumour lysis syndrome: new therapeutic strategies and classification;Cairo;British Journal of Haematology,2004
3. Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents;Cairo;Blood,2007
4. Safety, kinetics and outcome following rituximab (R) in combination with FAB chemotherapy in children and adolescents (C+A) with stage III/IV (Group B) and BM+/CNS+ (Group C) mature B-NHL: a Children's Oncology Group Report;Cairo;Journal of Clinical Oncology,2010a
5. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus;Cairo;British Journal of Haematology,2010b
Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tumour lysis syndrome;Nature Reviews Disease Primers;2024-08-22
2. CAR-T Cell Therapy in the Treatment of Pediatric Non-Hodgkin Lymphoma;Journal of Personalized Medicine;2023-11-10
3. Expert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: Results of a modified Delphi panel;Cancer Treatment Reviews;2023-11
4. Benefit of continuous kidney replacement therapy for managing tumor lysis syndrome in children with hematologic malignancies;Frontiers in Oncology;2023-08-18
5. Safety and Effectiveness of Rasburicase in the Control of Hyperuricemia in Pediatric Patients with Non-Hodgkin’s Lymphoma and Acute Leukemia: An Open-Label, Single-Arm, Multi-center, Interventional Study;Drugs in R&D;2023-05-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3